Molecular pathogenesis of thyroid cancer
JJ Figge, NA Kartel, D Yarmolinsky, G Ermak - Thyroid Cancer: A …, 2006 - Springer
The thyroid follicular epithelial cell (thyrocyte) responds to myriad growth-stimulating
substances, including hormones, growth factors, cytokines, and other mitogens (1–15), as …
substances, including hormones, growth factors, cytokines, and other mitogens (1–15), as …
Coding molecular determinants of thyroid cancer development and progression
V Valvo, C Nucera - Endocrinology and Metabolism Clinics, 2019 - endo.theclinics.com
Thyroid cancer not only is the most common malignancy of the endocrine system but also
shows an increased incidence rate, 1 overall increasing 3% annually. 2 The incidence …
shows an increased incidence rate, 1 overall increasing 3% annually. 2 The incidence …
Molecular markers involved in tumorigenesis of thyroid carcinoma: focus on aggressive histotypes
GC Penna, F Vaisman, M Vaisman… - … and genome research, 2017 - karger.com
Thyroid cancer derived from follicular cells (TCDFC) comprises well-differentiated (papillary
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …
and follicular) carcinoma, poorly differentiated carcinoma, and anaplastic carcinoma …
Molecular signaling in thyroid cancer
NJ Sarlis, S Benvenga - Molecular basis of thyroid cancer, 2004 - Springer
Molecular signaling–or signal transduction–is central to our understanding of the core
biological processes in any type of cancer. Defining the responses of cancerous cells to …
biological processes in any type of cancer. Defining the responses of cancerous cells to …
Biologic and clinical perspectives on thyroid cancer
JA Fagin, SA Wells Jr - New England Journal of Medicine, 2016 - Mass Medical Soc
Biologic and Clinical Perspectives on Thyroid Cancer | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
[PDF][PDF] Thyroid cancer: molecular pathogenesis, tyrosine kinase inhibitors, and other new therapies
TN Tanaka, SK Alloju, DK Oh… - Am J Hematol …, 2015 - gotoper-com.s3.amazonaws.com
Molecular testing in thyroid cancer proposes many novel approaches to this disease.
Traditional histologic diagnosis and classification of thyroid cancer may one day soon be …
Traditional histologic diagnosis and classification of thyroid cancer may one day soon be …
Signaling pathways in follicular cell-derived thyroid carcinomas
M Romitti, L Ceolin, DR Siqueira… - International …, 2013 - spandidos-publications.com
Thyroid carcinoma is the most common malignant endocrine neoplasia. Differentiated
thyroid carcinomas (DTCs) represent more than 90% of all thyroid carcinomas and comprise …
thyroid carcinomas (DTCs) represent more than 90% of all thyroid carcinomas and comprise …
[HTML][HTML] Pathogenesis of differentiated thyroid cancer (papillary and follicular)
Differentiated thyroid cancers (papillary-PTC and follicular-FTC) are the most common
endocrine malignancies. The recent progresses in the understanding of PTC and FTC …
endocrine malignancies. The recent progresses in the understanding of PTC and FTC …
Molecular pathology of thyroid tumours of follicular cells: a review of genetic alterations and their clinicopathological relevance
G Acquaviva, M Visani, A Repaci, KJ Rhoden… - …, 2018 - Wiley Online Library
Thyroid cancer is the most common endocrine malignancy. Knowledge of the molecular
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
pathology of thyroid tumours originating from follicular cells has greatly advanced in the past …
Genetic alterations in differentiated thyroid cancers
B Salehian, Z Liu, F Kandeel - Endocrine, Metabolic & Immune …, 2009 - ingentaconnect.com
Differentiated thyroid cancers are the predominant malignancies of the thyroid. Due to
advances in the understanding of the activation of the cell proliferation pathway at a …
advances in the understanding of the activation of the cell proliferation pathway at a …